Global Benign Prostatic Hyperplasia Devices Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
May, 2019
|
Report ID: 74880
|
130
|
Medical Devices
Benign prostatic hyperplasia (BPH) is a urological disorder characterized by non-cancerous proliferation of prostate gland cells. This condition causes the gland to enlarge and, as a result, press against the urethra, constricting urine flow. This disorder is associated with aging, hormone imbalances, and abnormal cell growth.
Scope of the Report:
This report focuses on the Benign Prostatic Hyperplasia Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The global benign prostatic hyperplasia market is expected to show considerable growth during the forecast period. This is attributed to rising geriatric population, increased awareness for prostate cancer and other urological disorders. However, the factors such as dearth of urologist in developing economies and lack of awareness regarding various urological diseases can hinder the growth of the market in the coming years. North America is account for the largest share of the benign prostatic hyperplasia market in 2016 due to high prevalence rate of benign prostatic hyperplasia. However, Asia is the fastest growing market due to the rise in various urological disorders and complications
The worldwide market for Benign Prostatic Hyperplasia Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Lumenis
Olympus corporation
Urologix
Boston Scientific corporation
Lisa Laser
Medifocus
Neotrac
ProArc Medical LTD
Urotech GMBH
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Transurethral Resection of the Prostate (TURP)
Transurethral Microwave Therapy (TUMT)
Transurethral Needle Ablation of the Prostate (TUNA)
Laser Surgery
Prostatic Stenting
Others
Market Segment by Applications, can be divided into
Hospitals and Clinics
Ambulatory Surgical Centers(ASC)
Home
Others
There are 15 Chapters to deeply display the global Benign Prostatic Hyperplasia Devices market.
Chapter 1, to describe Benign Prostatic Hyperplasia Devices Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Benign Prostatic Hyperplasia Devices, with sales, revenue, and price of Benign Prostatic Hyperplasia Devices, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Benign Prostatic Hyperplasia Devices, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Benign Prostatic Hyperplasia Devices market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Benign Prostatic Hyperplasia Devices sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Scope of the Report:
This report focuses on the Benign Prostatic Hyperplasia Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The global benign prostatic hyperplasia market is expected to show considerable growth during the forecast period. This is attributed to rising geriatric population, increased awareness for prostate cancer and other urological disorders. However, the factors such as dearth of urologist in developing economies and lack of awareness regarding various urological diseases can hinder the growth of the market in the coming years. North America is account for the largest share of the benign prostatic hyperplasia market in 2016 due to high prevalence rate of benign prostatic hyperplasia. However, Asia is the fastest growing market due to the rise in various urological disorders and complications
The worldwide market for Benign Prostatic Hyperplasia Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Lumenis
Olympus corporation
Urologix
Boston Scientific corporation
Lisa Laser
Medifocus
Neotrac
ProArc Medical LTD
Urotech GMBH
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Transurethral Resection of the Prostate (TURP)
Transurethral Microwave Therapy (TUMT)
Transurethral Needle Ablation of the Prostate (TUNA)
Laser Surgery
Prostatic Stenting
Others
Market Segment by Applications, can be divided into
Hospitals and Clinics
Ambulatory Surgical Centers(ASC)
Home
Others
There are 15 Chapters to deeply display the global Benign Prostatic Hyperplasia Devices market.
Chapter 1, to describe Benign Prostatic Hyperplasia Devices Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Benign Prostatic Hyperplasia Devices, with sales, revenue, and price of Benign Prostatic Hyperplasia Devices, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Benign Prostatic Hyperplasia Devices, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Benign Prostatic Hyperplasia Devices market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Benign Prostatic Hyperplasia Devices sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Benign Prostatic Hyperplasia Devices Introduction
1.2 Market Analysis by Type
1.2.1 Transurethral Resection of the Prostate (TURP)
1.2.2 Transurethral Microwave Therapy (TUMT)
1.2.3 Transurethral Needle Ablation of the Prostate (TUNA)
1.2.4 Laser Surgery
1.2.5 Prostatic Stenting
1.2.6 Others
1.3 Market Analysis by Applications
1.3.1 Hospitals and Clinics
1.3.2 Ambulatory Surgical Centers(ASC)
1.3.3 Home
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Lumenis
2.1.1 Business Overview
2.1.2 Benign Prostatic Hyperplasia Devices Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Lumenis Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Olympus corporation
2.2.1 Business Overview
2.2.2 Benign Prostatic Hyperplasia Devices Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Olympus corporation Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Urologix
2.3.1 Business Overview
2.3.2 Benign Prostatic Hyperplasia Devices Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Urologix Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Boston Scientific corporation
2.4.1 Business Overview
2.4.2 Benign Prostatic Hyperplasia Devices Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Lisa Laser
2.5.1 Business Overview
2.5.2 Benign Prostatic Hyperplasia Devices Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Lisa Laser Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Medifocus
2.6.1 Business Overview
2.6.2 Benign Prostatic Hyperplasia Devices Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Medifocus Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Neotrac
2.7.1 Business Overview
2.7.2 Benign Prostatic Hyperplasia Devices Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Neotrac Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 ProArc Medical LTD
2.8.1 Business Overview
2.8.2 Benign Prostatic Hyperplasia Devices Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Urotech GMBH
2.9.1 Business Overview
2.9.2 Benign Prostatic Hyperplasia Devices Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Urotech GMBH Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Benign Prostatic Hyperplasia Devices Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Benign Prostatic Hyperplasia Devices Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Benign Prostatic Hyperplasia Devices Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Benign Prostatic Hyperplasia Devices Manufacturer Market Share in 2017
3.3.2 Top 6 Benign Prostatic Hyperplasia Devices Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Benign Prostatic Hyperplasia Devices Market Analysis by Regions
4.1 Global Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Regions
4.1.1 Global Benign Prostatic Hyperplasia Devices Sales and Market Share by Regions (2013-2018)
4.1.2 Global Benign Prostatic Hyperplasia Devices Revenue and Market Share by Regions (2013-2018)
4.2 North America Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
4.3 Europe Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
4.5 South America Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
5 North America Benign Prostatic Hyperplasia Devices by Countries
5.1 North America Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Countries
5.1.1 North America Benign Prostatic Hyperplasia Devices Sales and Market Share by Countries (2013-2018)
5.1.2 North America Benign Prostatic Hyperplasia Devices Revenue and Market Share by Countries (2013-2018)
5.2 United States Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
5.3 Canada Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
5.4 Mexico Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
6 Europe Benign Prostatic Hyperplasia Devices by Countries
6.1 Europe Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Countries
6.1.1 Europe Benign Prostatic Hyperplasia Devices Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Benign Prostatic Hyperplasia Devices Revenue and Market Share by Countries (2013-2018)
6.2 Germany Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
6.3 UK Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
6.4 France Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
6.5 Russia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
6.6 Italy Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
7 Asia-Pacific Benign Prostatic Hyperplasia Devices by Countries
7.1 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Benign Prostatic Hyperplasia Devices Revenue and Market Share by Countries (2013-2018)
7.2 China Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
7.3 Japan Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
7.4 Korea Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
7.5 India Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
8 South America Benign Prostatic Hyperplasia Devices by Countries
8.1 South America Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Countries
8.1.1 South America Benign Prostatic Hyperplasia Devices Sales and Market Share by Countries (2013-2018)
8.1.2 South America Benign Prostatic Hyperplasia Devices Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
8.3 Argentina Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
8.4 Colombia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
9 Middle East and Africa Benign Prostatic Hyperplasia Devices by Countries
9.1 Middle East and Africa Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Benign Prostatic Hyperplasia Devices Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
9.3 UAE Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
9.4 Egypt Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
9.5 Nigeria Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
9.6 South Africa Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
10 Global Benign Prostatic Hyperplasia Devices Market Segment by Type
10.1 Global Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Benign Prostatic Hyperplasia Devices Sales and Market Share by Type (2013-2018)
10.1.2 Global Benign Prostatic Hyperplasia Devices Revenue and Market Share by Type (2013-2018)
10.2 Transurethral Resection of the Prostate (TURP) Sales Growth and Price
10.2.1 Global Transurethral Resection of the Prostate (TURP) Sales Growth (2013-2018)
10.2.2 Global Transurethral Resection of the Prostate (TURP) Price (2013-2018)
10.3 Transurethral Microwave Therapy (TUMT) Sales Growth and Price
10.3.1 Global Transurethral Microwave Therapy (TUMT) Sales Growth (2013-2018)
10.3.2 Global Transurethral Microwave Therapy (TUMT) Price (2013-2018)
10.4 Transurethral Needle Ablation of the Prostate (TUNA) Sales Growth and Price
10.4.1 Global Transurethral Needle Ablation of the Prostate (TUNA) Sales Growth (2013-2018)
10.4.2 Global Transurethral Needle Ablation of the Prostate (TUNA) Price (2013-2018)
10.5 Laser Surgery Sales Growth and Price
10.5.1 Global Laser Surgery Sales Growth (2013-2018)
10.5.2 Global Laser Surgery Price (2013-2018)
10.6 Prostatic Stenting Sales Growth and Price
10.6.1 Global Prostatic Stenting Sales Growth (2013-2018)
10.6.2 Global Prostatic Stenting Price (2013-2018)
10.7 Others Sales Growth and Price
10.7.1 Global Others Sales Growth (2013-2018)
10.7.2 Global Others Price (2013-2018)
11 Global Benign Prostatic Hyperplasia Devices Market Segment by Application
11.1 Global Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2013-2018)
11.2 Hospitals and Clinics Sales Growth (2013-2018)
11.3 Ambulatory Surgical Centers(ASC) Sales Growth (2013-2018)
11.4 Home Sales Growth (2013-2018)
11.5 Others Sales Growth (2013-2018)
12 Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)
12.1 Global Benign Prostatic Hyperplasia Devices Sales, Revenue and Growth Rate (2018-2023)
12.2 Benign Prostatic Hyperplasia Devices Market Forecast by Regions (2018-2023)
12.2.1 North America Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)
12.2.2 Europe Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)
12.2.3 Asia-Pacific Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)
12.2.4 South America Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)
12.2.5 Middle East and Africa Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)
12.3 Benign Prostatic Hyperplasia Devices Market Forecast by Type (2018-2023)
12.3.1 Global Benign Prostatic Hyperplasia Devices Sales Forecast by Type (2018-2023)
12.3.2 Global Benign Prostatic Hyperplasia Devices Market Share Forecast by Type (2018-2023)
12.4 Benign Prostatic Hyperplasia Devices Market Forecast by Application (2018-2023)
12.4.1 Global Benign Prostatic Hyperplasia Devices Sales Forecast by Application (2018-2023)
12.4.2 Global Benign Prostatic Hyperplasia Devices Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
1 Market Overview
1.1 Benign Prostatic Hyperplasia Devices Introduction
1.2 Market Analysis by Type
1.2.1 Transurethral Resection of the Prostate (TURP)
1.2.2 Transurethral Microwave Therapy (TUMT)
1.2.3 Transurethral Needle Ablation of the Prostate (TUNA)
1.2.4 Laser Surgery
1.2.5 Prostatic Stenting
1.2.6 Others
1.3 Market Analysis by Applications
1.3.1 Hospitals and Clinics
1.3.2 Ambulatory Surgical Centers(ASC)
1.3.3 Home
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Lumenis
2.1.1 Business Overview
2.1.2 Benign Prostatic Hyperplasia Devices Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Lumenis Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Olympus corporation
2.2.1 Business Overview
2.2.2 Benign Prostatic Hyperplasia Devices Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Olympus corporation Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Urologix
2.3.1 Business Overview
2.3.2 Benign Prostatic Hyperplasia Devices Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Urologix Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Boston Scientific corporation
2.4.1 Business Overview
2.4.2 Benign Prostatic Hyperplasia Devices Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Lisa Laser
2.5.1 Business Overview
2.5.2 Benign Prostatic Hyperplasia Devices Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Lisa Laser Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Medifocus
2.6.1 Business Overview
2.6.2 Benign Prostatic Hyperplasia Devices Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Medifocus Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Neotrac
2.7.1 Business Overview
2.7.2 Benign Prostatic Hyperplasia Devices Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Neotrac Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 ProArc Medical LTD
2.8.1 Business Overview
2.8.2 Benign Prostatic Hyperplasia Devices Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Urotech GMBH
2.9.1 Business Overview
2.9.2 Benign Prostatic Hyperplasia Devices Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Urotech GMBH Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Benign Prostatic Hyperplasia Devices Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Benign Prostatic Hyperplasia Devices Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Benign Prostatic Hyperplasia Devices Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Benign Prostatic Hyperplasia Devices Manufacturer Market Share in 2017
3.3.2 Top 6 Benign Prostatic Hyperplasia Devices Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Benign Prostatic Hyperplasia Devices Market Analysis by Regions
4.1 Global Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Regions
4.1.1 Global Benign Prostatic Hyperplasia Devices Sales and Market Share by Regions (2013-2018)
4.1.2 Global Benign Prostatic Hyperplasia Devices Revenue and Market Share by Regions (2013-2018)
4.2 North America Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
4.3 Europe Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
4.5 South America Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
5 North America Benign Prostatic Hyperplasia Devices by Countries
5.1 North America Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Countries
5.1.1 North America Benign Prostatic Hyperplasia Devices Sales and Market Share by Countries (2013-2018)
5.1.2 North America Benign Prostatic Hyperplasia Devices Revenue and Market Share by Countries (2013-2018)
5.2 United States Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
5.3 Canada Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
5.4 Mexico Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
6 Europe Benign Prostatic Hyperplasia Devices by Countries
6.1 Europe Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Countries
6.1.1 Europe Benign Prostatic Hyperplasia Devices Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Benign Prostatic Hyperplasia Devices Revenue and Market Share by Countries (2013-2018)
6.2 Germany Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
6.3 UK Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
6.4 France Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
6.5 Russia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
6.6 Italy Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
7 Asia-Pacific Benign Prostatic Hyperplasia Devices by Countries
7.1 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Benign Prostatic Hyperplasia Devices Revenue and Market Share by Countries (2013-2018)
7.2 China Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
7.3 Japan Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
7.4 Korea Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
7.5 India Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
8 South America Benign Prostatic Hyperplasia Devices by Countries
8.1 South America Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Countries
8.1.1 South America Benign Prostatic Hyperplasia Devices Sales and Market Share by Countries (2013-2018)
8.1.2 South America Benign Prostatic Hyperplasia Devices Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
8.3 Argentina Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
8.4 Colombia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
9 Middle East and Africa Benign Prostatic Hyperplasia Devices by Countries
9.1 Middle East and Africa Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Benign Prostatic Hyperplasia Devices Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
9.3 UAE Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
9.4 Egypt Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
9.5 Nigeria Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
9.6 South Africa Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
10 Global Benign Prostatic Hyperplasia Devices Market Segment by Type
10.1 Global Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Benign Prostatic Hyperplasia Devices Sales and Market Share by Type (2013-2018)
10.1.2 Global Benign Prostatic Hyperplasia Devices Revenue and Market Share by Type (2013-2018)
10.2 Transurethral Resection of the Prostate (TURP) Sales Growth and Price
10.2.1 Global Transurethral Resection of the Prostate (TURP) Sales Growth (2013-2018)
10.2.2 Global Transurethral Resection of the Prostate (TURP) Price (2013-2018)
10.3 Transurethral Microwave Therapy (TUMT) Sales Growth and Price
10.3.1 Global Transurethral Microwave Therapy (TUMT) Sales Growth (2013-2018)
10.3.2 Global Transurethral Microwave Therapy (TUMT) Price (2013-2018)
10.4 Transurethral Needle Ablation of the Prostate (TUNA) Sales Growth and Price
10.4.1 Global Transurethral Needle Ablation of the Prostate (TUNA) Sales Growth (2013-2018)
10.4.2 Global Transurethral Needle Ablation of the Prostate (TUNA) Price (2013-2018)
10.5 Laser Surgery Sales Growth and Price
10.5.1 Global Laser Surgery Sales Growth (2013-2018)
10.5.2 Global Laser Surgery Price (2013-2018)
10.6 Prostatic Stenting Sales Growth and Price
10.6.1 Global Prostatic Stenting Sales Growth (2013-2018)
10.6.2 Global Prostatic Stenting Price (2013-2018)
10.7 Others Sales Growth and Price
10.7.1 Global Others Sales Growth (2013-2018)
10.7.2 Global Others Price (2013-2018)
11 Global Benign Prostatic Hyperplasia Devices Market Segment by Application
11.1 Global Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2013-2018)
11.2 Hospitals and Clinics Sales Growth (2013-2018)
11.3 Ambulatory Surgical Centers(ASC) Sales Growth (2013-2018)
11.4 Home Sales Growth (2013-2018)
11.5 Others Sales Growth (2013-2018)
12 Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)
12.1 Global Benign Prostatic Hyperplasia Devices Sales, Revenue and Growth Rate (2018-2023)
12.2 Benign Prostatic Hyperplasia Devices Market Forecast by Regions (2018-2023)
12.2.1 North America Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)
12.2.2 Europe Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)
12.2.3 Asia-Pacific Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)
12.2.4 South America Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)
12.2.5 Middle East and Africa Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)
12.3 Benign Prostatic Hyperplasia Devices Market Forecast by Type (2018-2023)
12.3.1 Global Benign Prostatic Hyperplasia Devices Sales Forecast by Type (2018-2023)
12.3.2 Global Benign Prostatic Hyperplasia Devices Market Share Forecast by Type (2018-2023)
12.4 Benign Prostatic Hyperplasia Devices Market Forecast by Application (2018-2023)
12.4.1 Global Benign Prostatic Hyperplasia Devices Sales Forecast by Application (2018-2023)
12.4.2 Global Benign Prostatic Hyperplasia Devices Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Benign Prostatic Hyperplasia Devices Picture
Table Product Specifications of Benign Prostatic Hyperplasia Devices
Figure Global Sales Market Share of Benign Prostatic Hyperplasia Devices by Types in 2017
Table Benign Prostatic Hyperplasia Devices Types for Major Manufacturers
Figure Transurethral Resection of the Prostate (TURP) Picture
Figure Transurethral Microwave Therapy (TUMT) Picture
Figure Transurethral Needle Ablation of the Prostate (TUNA) Picture
Figure Laser Surgery Picture
Figure Prostatic Stenting Picture
Figure Others Picture
Figure Benign Prostatic Hyperplasia Devices Sales Market Share by Applications in 2017
Figure Hospitals and Clinics Picture
Figure Ambulatory Surgical Centers(ASC) Picture
Figure Home Picture
Figure Others Picture
Figure United States Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure France Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure UK Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure China Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure India Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Table Lumenis Basic Information, Manufacturing Base and Competitors
Table Lumenis Benign Prostatic Hyperplasia Devices Type and Applications
Table Lumenis Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Olympus corporation Basic Information, Manufacturing Base and Competitors
Table Olympus corporation Benign Prostatic Hyperplasia Devices Type and Applications
Table Olympus corporation Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Urologix Basic Information, Manufacturing Base and Competitors
Table Urologix Benign Prostatic Hyperplasia Devices Type and Applications
Table Urologix Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boston Scientific corporation Basic Information, Manufacturing Base and Competitors
Table Boston Scientific corporation Benign Prostatic Hyperplasia Devices Type and Applications
Table Boston Scientific corporation Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Lisa Laser Basic Information, Manufacturing Base and Competitors
Table Lisa Laser Benign Prostatic Hyperplasia Devices Type and Applications
Table Lisa Laser Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Medifocus Basic Information, Manufacturing Base and Competitors
Table Medifocus Benign Prostatic Hyperplasia Devices Type and Applications
Table Medifocus Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Neotrac Basic Information, Manufacturing Base and Competitors
Table Neotrac Benign Prostatic Hyperplasia Devices Type and Applications
Table Neotrac Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table ProArc Medical LTD Basic Information, Manufacturing Base and Competitors
Table ProArc Medical LTD Benign Prostatic Hyperplasia Devices Type and Applications
Table ProArc Medical LTD Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Urotech GMBH Basic Information, Manufacturing Base and Competitors
Table Urotech GMBH Benign Prostatic Hyperplasia Devices Type and Applications
Table Urotech GMBH Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Benign Prostatic Hyperplasia Devices Sales by Manufacturer (2016-2017)
Figure Global Benign Prostatic Hyperplasia Devices Sales Market Share by Manufacturer in 2016
Figure Global Benign Prostatic Hyperplasia Devices Sales Market Share by Manufacturer in 2017
Table Global Benign Prostatic Hyperplasia Devices Revenue by Manufacturer (2016-2017)
Figure Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Manufacturer in 2016
Figure Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Manufacturer in 2017
Figure Top 3 Benign Prostatic Hyperplasia Devices Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Benign Prostatic Hyperplasia Devices Manufacturer (Revenue) Market Share in 2017
Figure Global Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Global Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2013-2018)
Table Global Benign Prostatic Hyperplasia Devices Sales by Regions (2013-2018)
Table Global Benign Prostatic Hyperplasia Devices Sales Market Share by Regions (2013-2018)
Table Global Benign Prostatic Hyperplasia Devices Revenue by Regions (2013-2018)
Figure Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Regions in 2013
Figure Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Regions in 2017
Figure North America Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Europe Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure South America Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure North America Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2013-2018)
Table North America Benign Prostatic Hyperplasia Devices Sales by Countries (2013-2018)
Table North America Benign Prostatic Hyperplasia Devices Sales Market Share by Countries (2013-2018)
Figure North America Benign Prostatic Hyperplasia Devices Sales Market Share by Countries in 2013
Figure North America Benign Prostatic Hyperplasia Devices Sales Market Share by Countries in 2017
Table North America Benign Prostatic Hyperplasia Devices Revenue by Countries (2013-2018)
Table North America Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries (2013-2018)
Figure North America Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries in 2013
Figure North America Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries in 2017
Figure United States Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Canada Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Mexico Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Europe Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2013-2018)
Table Europe Benign Prostatic Hyperplasia Devices Sales by Countries (2013-2018)
Table Europe Benign Prostatic Hyperplasia Devices Sales Market Share by Countries (2013-2018)
Table Europe Benign Prostatic Hyperplasia Devices Revenue by Countries (2013-2018)
Figure Europe Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries in 2016
Figure Europe Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries in 2017
Figure Germany Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure UK Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure France Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Russia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Italy Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Benign Prostatic Hyperplasia Devices Sales by Countries (2013-2018)
Table Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Market Share by Countries 2017
Table Asia-Pacific Benign Prostatic Hyperplasia Devices Revenue by Countries (2013-2018)
Figure Asia-Pacific Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries 2017
Figure China Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Japan Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Korea Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure India Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Southeast Asia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure South America Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2013-2018)
Table South America Benign Prostatic Hyperplasia Devices Sales by Countries (2013-2018)
Table South America Benign Prostatic Hyperplasia Devices Sales Market Share by Countries (2013-2018)
Figure South America Benign Prostatic Hyperplasia Devices Sales Market Share by Countries in 2017
Table South America Benign Prostatic Hyperplasia Devices Revenue by Countries (2013-2018)
Table South America Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries (2013-2018)
Figure South America Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries in 2017
Figure Brazil Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Argentina Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Colombia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Benign Prostatic Hyperplasia Devices Sales by Countries (2013-2018)
Table Middle East and Africa Benign Prostatic Hyperplasia Devices Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Benign Prostatic Hyperplasia Devices Sales Market Share by Countries in 2017
Table Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue by Countries (2013-2018)
Table Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries in 2013
Figure Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries in 2017
Figure Saudi Arabia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure UAE Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Egypt Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Nigeria Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure South Africa Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Table Global Benign Prostatic Hyperplasia Devices Sales by Type (2013-2018)
Table Global Benign Prostatic Hyperplasia Devices Sales Share by Type (2013-2018)
Table Global Benign Prostatic Hyperplasia Devices Revenue by Type (2013-2018)
Table Global Benign Prostatic Hyperplasia Devices Revenue Share by Type (2013-2018)
Figure Global Transurethral Resection of the Prostate (TURP) Sales Growth (2013-2018)
Figure Global Transurethral Resection of the Prostate (TURP) Price (2013-2018)
Figure Global Transurethral Microwave Therapy (TUMT) Sales Growth (2013-2018)
Figure Global Transurethral Microwave Therapy (TUMT) Price (2013-2018)
Figure Global Transurethral Needle Ablation of the Prostate (TUNA) Sales Growth (2013-2018)
Figure Global Transurethral Needle Ablation of the Prostate (TUNA) Price (2013-2018)
Figure Global Laser Surgery Sales Growth (2013-2018)
Figure Global Laser Surgery Price (2013-2018)
Figure Global Prostatic Stenting Sales Growth (2013-2018)
Figure Global Prostatic Stenting Price (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Others Price (2013-2018)
Table Global Benign Prostatic Hyperplasia Devices Sales by Application (2013-2018)
Table Global Benign Prostatic Hyperplasia Devices Sales Share by Application (2013-2018)
Figure Global Ambulatory Surgical Centers(ASC) Sales Growth (2013-2018)
Figure Global Home Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Benign Prostatic Hyperplasia Devices Sales, Revenue and Growth Rate (2018-2023)
Table Global Benign Prostatic Hyperplasia Devices Sales Forecast by Regions (2018-2023)
Table Global Benign Prostatic Hyperplasia Devices Market Share Forecast by Regions (2018-2023)
Figure North America Sales Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)
Figure Europe Sales Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)
Figure Asia-Pacific Sales Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)
Figure South America Sales Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)
Figure Middle East and Africa Sales Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)
Table Global Benign Prostatic Hyperplasia Devices Sales Forecast by Type (2018-2023)
Table Global Benign Prostatic Hyperplasia Devices Market Share Forecast by Type (2018-2023)
Table Global Benign Prostatic Hyperplasia Devices Sales Forecast by Application (2018-2023)
Table Global Benign Prostatic Hyperplasia Devices Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
Figure Benign Prostatic Hyperplasia Devices Picture
Table Product Specifications of Benign Prostatic Hyperplasia Devices
Figure Global Sales Market Share of Benign Prostatic Hyperplasia Devices by Types in 2017
Table Benign Prostatic Hyperplasia Devices Types for Major Manufacturers
Figure Transurethral Resection of the Prostate (TURP) Picture
Figure Transurethral Microwave Therapy (TUMT) Picture
Figure Transurethral Needle Ablation of the Prostate (TUNA) Picture
Figure Laser Surgery Picture
Figure Prostatic Stenting Picture
Figure Others Picture
Figure Benign Prostatic Hyperplasia Devices Sales Market Share by Applications in 2017
Figure Hospitals and Clinics Picture
Figure Ambulatory Surgical Centers(ASC) Picture
Figure Home Picture
Figure Others Picture
Figure United States Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure France Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure UK Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure China Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure India Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Benign Prostatic Hyperplasia Devices Revenue (Value) and Growth Rate (2013-2023)
Table Lumenis Basic Information, Manufacturing Base and Competitors
Table Lumenis Benign Prostatic Hyperplasia Devices Type and Applications
Table Lumenis Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Olympus corporation Basic Information, Manufacturing Base and Competitors
Table Olympus corporation Benign Prostatic Hyperplasia Devices Type and Applications
Table Olympus corporation Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Urologix Basic Information, Manufacturing Base and Competitors
Table Urologix Benign Prostatic Hyperplasia Devices Type and Applications
Table Urologix Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boston Scientific corporation Basic Information, Manufacturing Base and Competitors
Table Boston Scientific corporation Benign Prostatic Hyperplasia Devices Type and Applications
Table Boston Scientific corporation Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Lisa Laser Basic Information, Manufacturing Base and Competitors
Table Lisa Laser Benign Prostatic Hyperplasia Devices Type and Applications
Table Lisa Laser Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Medifocus Basic Information, Manufacturing Base and Competitors
Table Medifocus Benign Prostatic Hyperplasia Devices Type and Applications
Table Medifocus Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Neotrac Basic Information, Manufacturing Base and Competitors
Table Neotrac Benign Prostatic Hyperplasia Devices Type and Applications
Table Neotrac Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table ProArc Medical LTD Basic Information, Manufacturing Base and Competitors
Table ProArc Medical LTD Benign Prostatic Hyperplasia Devices Type and Applications
Table ProArc Medical LTD Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Urotech GMBH Basic Information, Manufacturing Base and Competitors
Table Urotech GMBH Benign Prostatic Hyperplasia Devices Type and Applications
Table Urotech GMBH Benign Prostatic Hyperplasia Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Benign Prostatic Hyperplasia Devices Sales by Manufacturer (2016-2017)
Figure Global Benign Prostatic Hyperplasia Devices Sales Market Share by Manufacturer in 2016
Figure Global Benign Prostatic Hyperplasia Devices Sales Market Share by Manufacturer in 2017
Table Global Benign Prostatic Hyperplasia Devices Revenue by Manufacturer (2016-2017)
Figure Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Manufacturer in 2016
Figure Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Manufacturer in 2017
Figure Top 3 Benign Prostatic Hyperplasia Devices Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Benign Prostatic Hyperplasia Devices Manufacturer (Revenue) Market Share in 2017
Figure Global Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Global Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2013-2018)
Table Global Benign Prostatic Hyperplasia Devices Sales by Regions (2013-2018)
Table Global Benign Prostatic Hyperplasia Devices Sales Market Share by Regions (2013-2018)
Table Global Benign Prostatic Hyperplasia Devices Revenue by Regions (2013-2018)
Figure Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Regions in 2013
Figure Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Regions in 2017
Figure North America Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Europe Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure South America Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure North America Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2013-2018)
Table North America Benign Prostatic Hyperplasia Devices Sales by Countries (2013-2018)
Table North America Benign Prostatic Hyperplasia Devices Sales Market Share by Countries (2013-2018)
Figure North America Benign Prostatic Hyperplasia Devices Sales Market Share by Countries in 2013
Figure North America Benign Prostatic Hyperplasia Devices Sales Market Share by Countries in 2017
Table North America Benign Prostatic Hyperplasia Devices Revenue by Countries (2013-2018)
Table North America Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries (2013-2018)
Figure North America Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries in 2013
Figure North America Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries in 2017
Figure United States Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Canada Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Mexico Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Europe Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2013-2018)
Table Europe Benign Prostatic Hyperplasia Devices Sales by Countries (2013-2018)
Table Europe Benign Prostatic Hyperplasia Devices Sales Market Share by Countries (2013-2018)
Table Europe Benign Prostatic Hyperplasia Devices Revenue by Countries (2013-2018)
Figure Europe Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries in 2016
Figure Europe Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries in 2017
Figure Germany Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure UK Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure France Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Russia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Italy Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Benign Prostatic Hyperplasia Devices Sales by Countries (2013-2018)
Table Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Market Share by Countries 2017
Table Asia-Pacific Benign Prostatic Hyperplasia Devices Revenue by Countries (2013-2018)
Figure Asia-Pacific Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries 2017
Figure China Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Japan Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Korea Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure India Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Southeast Asia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure South America Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2013-2018)
Table South America Benign Prostatic Hyperplasia Devices Sales by Countries (2013-2018)
Table South America Benign Prostatic Hyperplasia Devices Sales Market Share by Countries (2013-2018)
Figure South America Benign Prostatic Hyperplasia Devices Sales Market Share by Countries in 2017
Table South America Benign Prostatic Hyperplasia Devices Revenue by Countries (2013-2018)
Table South America Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries (2013-2018)
Figure South America Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries in 2017
Figure Brazil Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Argentina Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Colombia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Benign Prostatic Hyperplasia Devices Sales by Countries (2013-2018)
Table Middle East and Africa Benign Prostatic Hyperplasia Devices Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Benign Prostatic Hyperplasia Devices Sales Market Share by Countries in 2017
Table Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue by Countries (2013-2018)
Table Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries in 2013
Figure Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries in 2017
Figure Saudi Arabia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure UAE Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Egypt Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure Nigeria Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Figure South Africa Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2013-2018)
Table Global Benign Prostatic Hyperplasia Devices Sales by Type (2013-2018)
Table Global Benign Prostatic Hyperplasia Devices Sales Share by Type (2013-2018)
Table Global Benign Prostatic Hyperplasia Devices Revenue by Type (2013-2018)
Table Global Benign Prostatic Hyperplasia Devices Revenue Share by Type (2013-2018)
Figure Global Transurethral Resection of the Prostate (TURP) Sales Growth (2013-2018)
Figure Global Transurethral Resection of the Prostate (TURP) Price (2013-2018)
Figure Global Transurethral Microwave Therapy (TUMT) Sales Growth (2013-2018)
Figure Global Transurethral Microwave Therapy (TUMT) Price (2013-2018)
Figure Global Transurethral Needle Ablation of the Prostate (TUNA) Sales Growth (2013-2018)
Figure Global Transurethral Needle Ablation of the Prostate (TUNA) Price (2013-2018)
Figure Global Laser Surgery Sales Growth (2013-2018)
Figure Global Laser Surgery Price (2013-2018)
Figure Global Prostatic Stenting Sales Growth (2013-2018)
Figure Global Prostatic Stenting Price (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Others Price (2013-2018)
Table Global Benign Prostatic Hyperplasia Devices Sales by Application (2013-2018)
Table Global Benign Prostatic Hyperplasia Devices Sales Share by Application (2013-2018)
Figure Global Ambulatory Surgical Centers(ASC) Sales Growth (2013-2018)
Figure Global Home Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Benign Prostatic Hyperplasia Devices Sales, Revenue and Growth Rate (2018-2023)
Table Global Benign Prostatic Hyperplasia Devices Sales Forecast by Regions (2018-2023)
Table Global Benign Prostatic Hyperplasia Devices Market Share Forecast by Regions (2018-2023)
Figure North America Sales Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)
Figure Europe Sales Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)
Figure Asia-Pacific Sales Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)
Figure South America Sales Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)
Figure Middle East and Africa Sales Benign Prostatic Hyperplasia Devices Market Forecast (2018-2023)
Table Global Benign Prostatic Hyperplasia Devices Sales Forecast by Type (2018-2023)
Table Global Benign Prostatic Hyperplasia Devices Market Share Forecast by Type (2018-2023)
Table Global Benign Prostatic Hyperplasia Devices Sales Forecast by Application (2018-2023)
Table Global Benign Prostatic Hyperplasia Devices Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
